Format

Send to

Choose Destination
See comment in PubMed Commons below
Expert Opin Investig Drugs. 2008 Jun;17(6):965-8. doi: 10.1517/13543784.17.6.965 .

PDE5 inhibitors for cystic fibrosis: can they also enhance chloride transport? Evaluation of: Lubamba B, Lecourt H, Lebacq J, et al. Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis. Am J Respir Crit Care Med 2008;177(5):506-15.

Author information

1
University of Medicine and Pharmacy Iasi, Pulmonary Disease University Hospital, Division of Pulmonary Disease, 30 Dr I Cihac Street, 700115 Iasi, Romania. sabina.antonela.antoniu@pneum. umfiasi.ro

Abstract

BACKGROUND:

Many compounds are currently under investigation for cystic fibrosis (CF), a genetic disorder caused by various mutations in cystic fibrosis transmembrane regulator (CFTR).

OBJECTIVE:

To evaluate a preclinical study on the effects of sildenafil and vardenafil, two PDE5 inhibitors, on ion transport in CF animal models.

METHODS/RESULTS:

The effects of sildenafil and vardenafil on chloride and sodium conductance were assessed in both DeltaF508CFTR and CFTR knockout mice models. They improved chloride transport in the DeltaF508CFTR model and had no effects in the CFTR knockout model.

CONCLUSION:

Sildenafil and vardenafil are promising agents for CF therapy provided they also demonstrate clinical efficacy.

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center